Literature DB >> 14651721

Dose estimation for children.

Nigel Baber1, Deborah Pritchard.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14651721      PMCID: PMC1884401          DOI: 10.1046/j.1365-2125.2003.01901.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  22 in total

Review 1.  Drug trials in children: problems and the way forward.

Authors:  S Conroy; J McIntyre; I Choonara; T Stephenson
Journal:  Br J Clin Pharmacol       Date:  2000-02       Impact factor: 4.335

2.  Unlicensed and off label drug use in neonates.

Authors:  S Conroy; J McIntyre; I Choonara
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1999-03       Impact factor: 5.747

3.  Chloramphenicol in the newborn infant. A physiologic explanation of its toxicity when given in excessive doses.

Authors:  C F WEISS; A J GLAZKO; J K WESTON
Journal:  N Engl J Med       Date:  1960-04-21       Impact factor: 91.245

4.  Survey of unlicensed and off label drug use in paediatric wards in European countries. European Network for Drug Investigation in Children.

Authors:  S Conroy; I Choonara; P Impicciatore; A Mohn; H Arnell; A Rane; C Knoeppel; H Seyberth; C Pandolfini; M P Raffaelli; F Rocchi; M Bonati; G Jong; M de Hoog; J van den Anker
Journal:  BMJ       Date:  2000-01-08

5.  Use of "off-label" and unlicensed drugs in paediatric intensive care unit.

Authors:  S Turner; A Gill; T Nunn; B Hewitt; I Choonara
Journal:  Lancet       Date:  1996-02-24       Impact factor: 79.321

6.  Survey of adrenal crisis associated with inhaled corticosteroids in the United Kingdom.

Authors:  G R G Todd; C L Acerini; R Ross-Russell; S Zahra; J T Warner; D McCance
Journal:  Arch Dis Child       Date:  2002-12       Impact factor: 3.791

7.  Surveillance for fatal suspected adverse drug reactions in the UK.

Authors:  A Clarkson; I Choonara
Journal:  Arch Dis Child       Date:  2002-12       Impact factor: 3.791

Review 8.  Unlicensed and off-label uses of drugs in paediatrics: a review of the literature.

Authors:  Laura Cuzzolin; Ada Zaccaron; Vassilios Fanos
Journal:  Fundam Clin Pharmacol       Date:  2003-02       Impact factor: 2.748

9.  Adverse drug reactions to unlicensed and off-label drugs on paediatric wards: a prospective study.

Authors:  S Turner; A J Nunn; K Fielding; I Choonara
Journal:  Acta Paediatr       Date:  1999-09       Impact factor: 2.299

10.  Adverse drug reactions and off-label drug use in paediatric outpatients.

Authors:  Benjamin Horen; Jean-Louis Montastruc; Maryse Lapeyre-Mestre
Journal:  Br J Clin Pharmacol       Date:  2002-12       Impact factor: 4.335

View more
  12 in total

Review 1.  Tripartite meeting. Paediatric regulatory guidelines: do they help in optimizing dose selection for children?

Authors:  N S Baber
Journal:  Br J Clin Pharmacol       Date:  2005-06       Impact factor: 4.335

2.  Prediction of cytochrome p450-mediated hepatic drug clearance in neonates, infants and children : how accurate are available scaling methods?

Authors:  Sven Björkman
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

3.  A predictive pharmacokinetic/pharmacodynamic model of fentanyl for analgesia/sedation in neonates based on a semi-physiologic approach.

Authors:  Esther Encinas; Rosario Calvo; John C Lukas; Valvanera Vozmediano; Monica Rodriguez; Elena Suarez
Journal:  Paediatr Drugs       Date:  2013-06       Impact factor: 3.022

Review 4.  Paediatric pharmacokinetics and drug doses.

Authors:  Kate O'Hara
Journal:  Aust Prescr       Date:  2016-12-05

Review 5.  Interventions of hospital pharmacists in improving drug therapy in children: a systematic literature review.

Authors:  Navneet Sanghera; Po-Yi Chan; Zahra F Khaki; Claire Planner; Kenneth K C Lee; Noël E Cranswick; Ian C K Wong
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

6.  Prediction of the clearance of eleven drugs and associated variability in neonates, infants and children.

Authors:  Trevor N Johnson; Amin Rostami-Hodjegan; Geoffrey T Tucker
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

7.  Prediction of drug disposition in infants and children by means of physiologically based pharmacokinetic (PBPK) modelling: theophylline and midazolam as model drugs.

Authors:  Sven Björkman
Journal:  Br J Clin Pharmacol       Date:  2005-06       Impact factor: 4.335

8.  Vancomycin pharmacokinetics in preterm neonates and the prediction of adult clearance.

Authors:  Brian J Anderson; Karel Allegaert; John N Van den Anker; Veerle Cossey; Nicholas H G Holford
Journal:  Br J Clin Pharmacol       Date:  2006-07-21       Impact factor: 4.335

Review 9.  Inter-individual variation in morphine clearance in children.

Authors:  Mohammed I Altamimi; Imti Choonara; Helen Sammons
Journal:  Eur J Clin Pharmacol       Date:  2015-04-08       Impact factor: 2.953

Review 10.  Inter-individual variation in midazolam clearance in children.

Authors:  Mohammed I Altamimi; Helen Sammons; Imti Choonara
Journal:  Arch Dis Child       Date:  2014-10-03       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.